- Home
- IRTC
as 09-17-2025 4:00pm EST
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | San Francisco |
| Market Cap: | 5.8B | IPO Year: | 2016 |
| Target Price: | $163.82 | AVG Volume (30 days): | 378.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 11 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $55.92 - $187.57 | Next Earning Date: | 10-29-2025 |
| Revenue: | $657,227,000 | Revenue Growth: | 22.37% |
| Revenue Growth (this year): | 25.11% | Revenue Growth (next year): | 16.65% |
Stock Insider Trading Activity of iRhythm Technologies Inc. (IRTC)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Wilson Daniel G. | IRTC | Chief Financial Officer | Sep 3 '25 | Sell | $175.00 | 5,000 | $875,000.00 | 34,470 | |
| Wilson Daniel G. | IRTC | Chief Financial Officer | Sep 2 '25 | Sell | $167.28 | 737 | $123,285.36 | 34,470 | |
| Shrishrimal Sumi | IRTC | EVP, Chief Risk Officer | Aug 22 '25 | Sell | $167.12 | 653 | $109,129.36 | 34,032 | |
| Rosenbaum Marc W. | IRTC | Chief Accounting Officer | Aug 11 '25 | Sell | $158.93 | 226 | $35,918.18 | 10,879 | |
| TALWALKAR ABHIJIT Y | IRTC | N/A | Aug 11 '25 | Sell | $158.13 | 5,312 | $839,380.65 | 22,428 |
Latest iRhythm Technologies Inc. News
IRTC Breaking Stock News: Dive into IRTC Ticker-Specific Updates for Smart Investing
Simply Wall St.
25 days ago
Interested In Olin's (NYSE:OLN) Upcoming US$0.20 Dividend? You Have Three Days Left
Simply Wall St.
25 days ago
Is Magna International Inc. (TSE:MG) Potentially Undervalued?
Financial Times
25 days ago
HSBC Swiss unit culls wealthy Middle Eastern clients amid regulator scrutiny
Simply Wall St.
25 days ago
Why You Might Be Interested In CSX Corporation (NASDAQ:CSX) For Its Upcoming Dividend
Simply Wall St.
25 days ago
Those who invested in SWK Holdings (NASDAQ:SWKH) three years ago are up 4.0%
Simply Wall St.
25 days ago
BJ's Wholesale Club Holdings Second Quarter 2026 Earnings: EPS Beats Expectations, Revenues Lag
Simply Wall St.
25 days ago
Here's Why We're Watching Boundless Bio's (NASDAQ:BOLD) Cash Burn Situation
GOBankingRates
25 days ago
The One Dangerous Habit Keeping You in Credit Card Debt, According to Liz Claman
Compare IRTC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IRTC iRhythm Technologies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.